When to visit the vet?
Non-urgent see a veterinarian within 2–3 days
If the condition worsens / symptoms persist, consult a veterinarian.
Definition
Pythiosis is a rare but serious infectious disease in dogs caused by the water mold Pythium insidiosum. This disease can affect various tissues, particularly the skin and gastrointestinal tract.
The most important facts at a glance
Pythiosis in dogs is caused by the water mold Pythium insidiosum, which thrives in warm, humid environments such as stagnant water. Dogs that swim in such water are at increased risk of infection. The pathogen enters the body through small skin injuries or mucous membranes and causes granulomatous inflammatory conditions that are difficult to treat. Symptoms include fever, vomiting, diarrhea, weight loss, and enlarged lymph nodes. Diagnosis requires special laboratory tests, imaging, and biopsies, which is often delayed due to the rarity of the disease.
Treatment is complex and combines surgical interventions with the administration of antifungals such as itraconazole or terbinafine, as conventional agents are often ineffective. Immunotherapy may help in some cases but is expensive and not always successful. The prognosis is guarded to poor, especially with late diagnoses or systemic spread. Early intervention can improve survival chances. Prevention includes avoiding contaminated water, regular skin checks, and, if necessary, prophylactic immune strengthening. Avoiding contact with potentially contaminated water remains the most effective prevention strategy.
Causes
Pythium insidiosum belongs to the class of oomycetes, which despite their fungal-like properties are more closely related to algae. This water mold thrives in warm, humid environments, particularly in stagnant or slow-moving water. Dogs that frequently swim in or spend time near such water are at higher risk.
Infection occurs primarily through contact with contaminated water, with the water mold entering the body through small skin injuries or mucous membranes. The high prevalence of the disease in tropical and subtropical regions is due to optimal climatic conditions for pathogen growth.
Pythium insidiosum is able to survive in host tissue and trigger strong inflammatory reactions. This leads to granulomatous lesions that are difficult to treat. The exact pathogenesis is complex and involves a variety of immunological reactions that ultimately lead to tissue damage and loss of function.
Symptoms
The symptoms of pythiosis in dogs vary depending on the affected tissue. In skin infections, dogs can develop nodular, ulcerating lesions that are often severely itchy and painful. These lesions tend to spread rapidly and can lead to secondary bacterial infections.
If the gastrointestinal tract is affected, symptoms such as vomiting, diarrhea, weight loss, and loss of appetite can occur. The extensive tissue damage can lead to thickening of the intestinal walls and, in severe cases, to intestinal obstruction. These symptoms are often nonspecific and can be confused with those of other gastrointestinal diseases.
In some cases, the infection can also become systemic, leading to Fever, general weakness, and signs of sepsis. The clinical picture can be highly variable, making diagnosis difficult.
Therapy
Treatment of pythiosis is challenging and often requires a combination of surgical and medical approaches. For cutaneous lesions, early surgical removal of infected tissue is crucial to prevent the spread of infection. In gastrointestinal infections, resection of affected intestinal segments may also be necessary.
Medically, the infection is often treated with a combination of antifungal and immunomodulatory medications. Since Pythium insidiosum does not respond to conventional antifungals, specific agents such as itraconazole or terbinafine are used. These medications must be administered over extended periods to achieve complete elimination of the pathogen.
In some cases, immunotherapy may be considered to strengthen the dog’s immune system and improve defense against the pathogen. However, these treatment methods are often expensive and not always successful.
Prognosis and follow-up care
The prognosis for dogs with pythiosis is generally guarded to poor, especially if the disease is diagnosed late or has already taken on systemic proportions. Early diagnosis and aggressive treatment can improve survival chances, but the risk of recurrence of the infection remains.
Dogs that receive complete surgical removal of infected tissue and respond well to medical treatment have the best chances of recovery. Nevertheless, the long-term prognosis depends on the severity of the disease and the response to therapy.
Without treatment, the disease can progress rapidly and lead to death within a few months. Careful monitoring of dogs living in high-risk areas or frequently swimming in stagnant waters is crucial for rapid intervention and treatment.
Prevention
Since pythiosis is mainly prevalent in certain geographic regions, an essential prevention measure is to keep dogs away from potentially contaminated water, especially during the warm and humid months of the year.
Regular skin checks for injuries or unusual changes can help detect early infections and respond more quickly. For dogs living or working in risk areas, good hygiene should be maintained to minimize the risk of infection.
In some cases, prophylactic treatment with immune-boosting supplements may be considered, especially for dogs with known risk or in areas with high disease prevalence. Nevertheless, avoiding contact with contaminated water sources remains the most effective prevention strategy.
Outlook on current research
Pythiosis in dogs is a severe, often rapidly progressive disease caused by Pythium insidiosum. Despite the name, it is not a true fungus but an oomycete. This is crucial for research because many classic antifungals are only limitedly effective against it. Particularly common in dogs are the gastrointestinal and cutaneous/subcutaneous forms, and the prognosis depends heavily on how early the disease is detected. (merckvetmanual.com, pubmed.ncbi.nlm.nih.gov)
The most important research outlook today lies in earlier and more precise diagnostics. Clinically, pythiosis can deceptively mimic other inflammatory or neoplastic processes. Therefore, serology, PCR, histopathology, and immunohistochemical methods are being further improved to distinguish the disease more quickly and reliably. (pubmed.ncbi.nlm.nih.gov, merckvetmanual.com)
A second focus is therapy development. Since standard antifungals are often insufficient, radical surgical removal remains central, provided it is anatomically possible. In parallel, research is investigating combined medical strategies and immunotherapies to reduce relapses and better treat inoperable cases. (pubmed.ncbi.nlm.nih.gov, pubmed.ncbi.nlm.nih.gov)
Overall, the outlook is cautiously optimistic: progress is expected primarily through faster diagnostics, better understanding of oomycete biology, and more targeted combination treatments.
Frequently Asked Questions (FAQs)
1. What is pythiosis?
2. How do dogs become infected?
3. Which breeds are particularly affected?
4. What symptoms occur?
5. How is the diagnosis made?
6. How is pythiosis treated?
7. Why is medical therapy often ineffective?
8. What is the prognosis?
9. Is pythiosis contagious?
10. How can it be prevented?
Literature
- Cridge, H. (2025). Pythiosis in dogs. Veterinary Clinics of North America: Small Animal Practice, 55(2), 225–236. https://doi.org/10.1016/j.cvsm.2024.11.008
- Billings, P., Walton, S., Shmalberg, J., & Santoro, D. (2023). The use of mefenoxam to treat cutaneous and gastrointestinal pythiosis in dogs: A retrospective study. Microorganisms, 11(7), Article 1726. https://doi.org/10.3390/microorganisms11071726
- Hamlin, A. N., Locker, S., Huguet, E., Berry, C. R., Cole, R., Griffin, J. F., IV, Gremillion, C., Hecht, S., & Vilaplana Grosso, F. R. (2024). Computed tomographic characteristics of confirmed and presumed noncutaneous pythiosis in 25 dogs. Veterinary Radiology & Ultrasound, 65(2), 87–98. https://doi.org/10.1111/vru.13326
- Yolanda, H., & Krajaejun, T. (2022). Global distribution and clinical features of pythiosis in humans and animals. Journal of Fungi, 8(2), Article 182. https://doi.org/10.3390/jof8020182
- Reagan, K. L., Marks, S. L., Pesavento, P. A., & Grooters, A. M. (2019). Successful management of 3 dogs with colonic pythiosis using itraconazole, terbinafine, and prednisone. Journal of Veterinary Internal Medicine, 33(3), 1434–1439. https://doi.org/10.1111/jvim.15506
- Berryessa, N. A., Marks, S. L., Pesavento, P. A., Krasnansky, T., Yoshimoto, S. K., Johnson, E. G., & Grooters, A. M. (2008). Gastrointestinal pythiosis in 10 dogs from California. Journal of Veterinary Internal Medicine, 22(4), 1065–1069. https://doi.org/10.1111/j.1939-1676.2008.0123.x
- Grooters, A. M. (2003). Pythiosis, lagenidiosis, and zygomycosis in small animals. Veterinary Clinics of North America: Small Animal Practice, 33(4), 695–720. https://doi.org/10.1016/S0195-5616(03)00034-2